Detailed programme:
| Time | Day 1 (Friday, 20 May 2005) | Day 2 (Saturday, 21 May 2005) |
| 0830 – 0930 | Plenary | |
| Current Progress in The treatment of Adult Acute Myeloid Leukaemia (Prof. Newland) | ||
| 0930 - 1030 | Symposium 3 - Platelet disorders | |
| ITP – investigation and novel therapy (Prof. Newland) | ||
| HITS (Dr. Puru) | ||
| 1030 – 1100 | Tea | |
| 1100 – 1230 | Thrombotic thrombocytopenic purpura (Dr. Jameela) | |
| Role of FVIIa in platelet disorders - ?Novo Nordisk (Chang to identify) | ||
| 1230 – 1400 | Registration (Leong and co.) | Lunch (1/2 hour for Pfizer) – Evolving treatment options for invasive fungal infections Prof. Deborah Mariott |
| 1400 – 1430 | Case studies | |
| Penang – TBC | ||
| GHKL – Dr. Ong | ||
| HUKM – Dr. CF Leong | ||
| HUSM – Prof Aziz Baba | ||
| Ipoh Hospital – Dr. Padmini | ||
| Panelist | ||
| Dr. Puru | ||
| Dr. Newland | ||
| Dr. Leong K W | ||
| Prof. Cheong | ||
| 1430 – 1545 | ||
| Symposium 1 - Leukemia management | ||
| CML and Glivec – Dr. Alan Teh | ||
| Role of quantitative PCR – Dr. Veera | ||
| Transplant in CML – Dr. Chang | ||
| 1545 - 1600 | Tea | Tea |
| 1600 – 1730 | Symposium 2 - Myeloma | |
| Immunotherapy of MM – Dr. Fadilah | ||
| Transplant and myeloma – Dr. MH Saw | ||
| Amyloidosis – Prof. Looi | ||
| 1730 - 1830 | AGM | |